Cara Therapeutics Total Non Current Liabilities 2011-2026 | CARA

Annual Total Non Current Liabilities Cara Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	3.35 M	16.7 M	1.72 M	1.57 M	585 K	874 K	1.14 M	1.41 M	1.65 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16.7 M	585 K	3.23 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	69.4 M	$ 21.65	1.12 %	$ 1.01 B	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	2.21 M	$ 0.9	-0.18 %	$ 6.62 M	China
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	49.6 M	$ 22.3	1.55 %	$ 3.7 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	854 K	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	341 M	$ 102.06	-3.22 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	90.3 M	$ 4.1	0.49 %	$ 438 M	USA
Arcutis Biotherapeutics ARQT	167 M	$ 23.42	0.69 %	$ 2.98 B	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	50.6 M	$ 1.42	-1.39 %	$ 378 M	Britain
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	30.8 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	1.19 M	$ 2.92	-0.34 %	$ 4.81 M	Israel
Esperion Therapeutics ESPR	355 M	$ 1.91	-	$ 397 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
ContraFect Corporation CFRX	9.41 M	-	-5.16 %	$ 5.39 M	USA
Cardiff Oncology CRDF	451 K	$ 1.72	-	$ 115 M	USA
BioXcel Therapeutics BTAI	1.4 M	$ 1.09	2.83 %	$ 13.3 M	USA
Cabaletta Bio CABA	43.9 M	$ 2.91	-1.36 %	$ 292 M	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
CASI Pharmaceuticals CASI	38.2 M	-	-	$ 35.4 M	USA